Thailand Medical Tourism Infrastructure Development Feasibility Study with Healthcare Travel Market Outlook

Executive Viability Abstract

This feasibility study evaluates the development of a state-of-the-art medical tourism hub in Thailand, focusing on tertiary care and wellness integration. Thailand holds a 9% share of the global medical tourism market, and this project aims to capitalize on the 12.5% CAGR projected through 2030. The analysis confirms high viability driven by competitive pricing (30-70% lower than US/EU) and government 'Medical Hub' incentives.

## Market Analysis Thailand's medical tourism sector is recovering rapidly post-pandemic, with an expected 3.5 million international patients by 2026. Primary source markets include the GCC, China, and Australia. Key growth drivers include aging global populations and the expansion of the 'L-Long Term Resident' visa. ## Technical Feasibility The facility requires JCI (Joint Commission International) accreditation to attract premium international insurance providers. The infrastructure must include smart-ward integration, AI-driven diagnostics, and 5G-enabled telemedicine for post-operative international follow-ups. ## Capex Summary Total estimated investment is $150 Million. Allocation: Construction and Land (45%), Specialized Medical Equipment (30%), Digital Infrastructure (10%), and Pre-operating Capital (15%). ## Revenue Model Revenue is diversified across surgical procedures (40%), wellness and longevity packages (30%), pharmaceutical sales (15%), and diagnostic services (15%). Strategic partnerships with international insurance conglomerates (Allianz, Bupa) are critical for volume. ## Financial Projections Targeting an EBITDA margin of 28% by Year 3. Annual revenue growth is modeled at 18% for the first five years based on current patient inflow trends in the Bangkok and Phuket corridors.